Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, 420/6 Rajvithi Rd., Bangkok, 10400, Thailand.
Mahidol-Oxford Tropical Medicine Research Unit, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand.
Sci Rep. 2022 Apr 1;12(1):5563. doi: 10.1038/s41598-022-09474-5.
Well-defined molecular resistance markers are available for a range of antimalarial drugs, and molecular surveillance is increasingly important for monitoring antimalarial drug resistance. Different genotyping platforms are available, but these have not been compared in detail. We compared Targeted Amplicon Deep sequencing (TADs) using Ion Torrent PGM with Illumina MiSeq for the typing of antimalarial drug resistance genes. We developed and validated protocols to type the molecular resistance markers pfcrt, pfdhfr, pfdhps, pfmdr1, pfkelch, and pfcytochrome b, in Plasmodium falciparum for the Ion Torrent PGM and Illumina MiSeq sequencing platforms. With P. falciparum 3D7 and K1 as reference strains, whole blood samples (N = 20) and blood spots from Rapid Diagnostic Test (RDT) samples (N = 5) from patients with uncomplicated falciparum malaria from Ubon Ratchathani were assessed on both platforms and compared for coverage (average reads per amplicon), sequencing accuracy, variant accuracy, false positive rate, false negative rate, and alternative allele detection, with conventional Sanger sequencing as the reference method for SNP calling. Both whole blood and RDT samples could be successfully sequenced using the Ion Torrent PGM and Illumina MiSeq platforms. Coverage of reads per amplicon was higher with Illumina MiSeq (28,886 reads) than with Ion Torrent PGM (1754 reads). In laboratory generated artificial mixed infections, the two platforms could detect the minor allele down to 1% density at 500X coverage. SNPs calls from both platforms were in complete agreement with conventional Sanger sequencing. The methods can be multiplexed with up to 96 samples per run, which reduces cost by 86% compared to conventional Sanger sequencing. Both platforms, using the developed TAD protocols, provide an accurate method for molecular surveillance of drug resistance markers in P. falciparum, but Illumina MiSeq provides higher coverage than Ion Torrent PGM.
针对一系列抗疟药物,已经明确了分子耐药标志物,而分子监测对于监测抗疟药物耐药性变得愈发重要。目前已有多种基因分型平台,但尚未对其进行详细比较。我们比较了用于抗疟药物耐药基因分型的靶向扩增子深度测序(TADs)和 Illumina MiSeq 平台的 Ion Torrent PGM。我们开发并验证了针对 Ion Torrent PGM 和 Illumina MiSeq 测序平台的 PfCRT、PfDHFR、PfDHPS、PfMDR1、PfKelch 和 PfCytochrome b 分子耐药标志物的检测方案。以 Pf3D7 和 K1 作为参考株,我们在 Ion Torrent PGM 和 Illumina MiSeq 平台上评估了来自乌汶府疟疾病例的全血样本(N=20)和快速诊断检测(RDT)样本血斑(N=5),并比较了两种平台的覆盖度(每个扩增子的平均读数)、测序准确性、变异准确性、假阳性率、假阴性率和替代等位基因检测,以 Sanger 测序作为 SNP 调用的参考方法。全血和 RDT 样本都可以成功地在 Ion Torrent PGM 和 Illumina MiSeq 平台上进行测序。Illumina MiSeq(28886 个读数)的每个扩增子的读数覆盖度高于 Ion Torrent PGM(1754 个读数)。在实验室产生的人工混合感染中,两种平台都可以在 500X 覆盖度下检测到低至 1%密度的次要等位基因。两种平台的 SNP 调用都与 Sanger 测序完全一致。该方法可同时对 96 个样本进行多重检测,与传统 Sanger 测序相比,成本降低了 86%。使用开发的 TAD 方案,两种平台都可以为 Pf 疟疾耐药标志物的分子监测提供一种准确的方法,但 Illumina MiSeq 比 Ion Torrent PGM 提供了更高的覆盖度。